PSIPET Research Group

The PSIPET study at Karolinska Institute is the first Phase II randomized clinical trial in Sweden investigating psilocybin for depression. The research utilizes PET and MRI imaging to examine synaptic density and the biological mechanisms underlying psilocybin's therapeutic effects.